A proposal for financing postmarketing drug safety studies by augmenting FDA user fees (Q81370202)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 July 2005
edit
Language Label Description Also known as
English
A proposal for financing postmarketing drug safety studies by augmenting FDA user fees
scientific article published on 01 July 2005

    Statements

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit